Staton Financial Advisors’s AbbVie ABBV Stock Holding History

Staton Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.29M	Buy	59,160 +1,759	+3%	+$118K	3.64%	8
2017 Q1	$3.74M	Buy	57,401 +4,654	+9%	+$293K	3.21%	15
2016 Q4	$3.3M	Buy	52,747 +5,373	+11%	+$328K	2.98%	17
2016 Q3	$2.99M	Buy	47,374 +8,806	+23%	+$570K	2.74%	19
2016 Q2	$2.39M	Buy	38,568 +19,528	+103%	+$1.19M	2.19%	24
2016 Q1	$1.09M	Buy	+19,040	New	+$1.06M	1.04%	31

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Staton Financial Advisors's ABBV Position: Q2 2017 in Review

Staton Financial Advisors increased its AbbVie (ABBV) stake by 3.1% in Q2 2017, buying an estimated $118K and bringing the position to 59,160 shares worth $4.29M. The position accounts for 3.64% of the portfolio, ranked #8.

Staton Financial Advisors first reported a position in ABBV in Q1 2016 and has held it in 6 quarters since. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

Staton Financial Advisors held 59,160 shares of AbbVie worth $4.29M as of Q2 2017.
Staton Financial Advisors bought 1,759 AbbVie shares in Q2 2017, an estimated $118K.
AbbVie made up 3.64% of Staton Financial Advisors's portfolio in Q2 2017, its #8 holding.
Staton Financial Advisors first reported a position in AbbVie in Q1 2016 and has held it in 6 quarters since.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Staton Financial Advisors's 13F filing for Q2 2017, filed 27 Jul 2017.